In brief
UNAids Executive Director Winnie Byanyima warns that US funding cuts to HIV programs could lead to thousands of new infections and millions of deaths over the coming years, urging for an immediate reversal of these decisions.
US funding cuts will lead to a staggering surge in HIV infections and deaths, according to a stark warning from the Executive Director of UNAids, Winnie Byanyima. She predicted that an additional 2,000 new HIV infections will occur daily, resulting in over six million additional deaths within the next four years as a consequence of halted foreign aid programs.This alarming trend marks a significant regression in the global battle against HIV, with deaths dropping from more than two million in 2004 to approximately 600,000 in 2023—reflecting decades of progress now at risk. The cuts are directly related to the US government's recent decision to pause foreign aid, which particularly impacts funding for critical HIV programs.Speaking from Geneva, Byanyima expressed urgent concern, highlighting that women and girls disproportionately bear the brunt of these funding withdrawals. The US has long been the largest donor for HIV treatment and prevention worldwide; however, many programs faced abrupt stop-work orders, resulting in halted operations for mother-and-baby clinics across Africa and critical shortages of antiretroviral (ARV) medications.Byanyima voiced fears of a return to the dire conditions of the 1990s when HIV treatments were nearly inaccessible in poorer nations. She acknowledged long-term concerns about funding reductions but emphasized that "sudden withdrawal of lifesaving support [is] having a devastating impact," reinforcing calls for the US to reassess its course of action.Despite appeals for a change in policy, there has been no indication that the US administration is willing to reverse its decision. Concurrently, traditional European aid donors are also on the verge of reducing their contributions, leaving UNAids without alternative funding sources.The dire consequences are exemplified by the story of Juliana, a young woman in Kenya whose job was tied to a US-funded initiative helping new mothers access HIV treatments. The disruption of this program not only left her unemployed but also jeopardized her own treatment as a breastfeeding mother.The World Health Organization (WHO) has identified eight countries, including Nigeria and Kenya, that could experience severe shortages of HIV drugs due to these funding interruptions. WHO Director-General Tedros Adhanom Ghebreyesus warned that these disruptions threaten to undo two decades of progress in the fight against HIV.In a proactive gesture, Byanyima presented a proposal to the Trump administration, suggesting a collaboration to market a newly developed ARV, Lenacapavir, which could potentially benefit millions globally. She argued that such a partnership would not only save lives but would also generate profits and job opportunities within the US.UNAids is among several UN agencies grappling with funding cuts, which may lead to job losses and stalling of critical global health programs. The UN Refugee Agency is expected to eliminate thousands of jobs, while Unicef has highlighted threats to child mortality reduction efforts.
